Biomedicines (Apr 2024)

What Is the Role of Basal Weekly Insulin in Clinical Practice? The State of the Art

  • Christiano Argano,
  • Laura Priola,
  • Francesco Manno,
  • Salvatore Corrao

DOI
https://doi.org/10.3390/biomedicines12040900
Journal volume & issue
Vol. 12, no. 4
p. 900

Abstract

Read online

Despite the advent of innovative therapies in the treatment of diabetes, ever-increasing awareness is still directed to the role of insulin since it has continued to be at the centre of diabetes therapy for decades, as a therapeutic integration of innovative agents in type 2 diabetes mellitus (T2DM), as the only replacement therapy in type 1 diabetes mellitus (T1DM) and also in gestational diabetes. In this context, the study of molecules such as weekly basal insulins, both for their technological and pharmacodynamic innovation and their manageability and undoubted benefits in compliance with drug therapy, can only be a turning point in diabetes and for all its phenotypes. This review aims to provide insight into the knowledge of basal weekly insulins and their use in type 1 and 2 diabetes mellitus by examining their safety, efficacy, manageability and increased therapeutic compliance.

Keywords